Form 4: Rallybio Corp CFO Jonathan Lieber Acquires 180,000 Stock Options
SEC Form 4 Filing
Jonathan Lieber, CFO of Rallybio Corp, reports the acquisition of 180,000 stock options on February 14, 2025.
Summary
- On February 14, 2025, Jonathan Lieber, the Chief Financial Officer of Rallybio Corp, acquired 180,000 stock options.
- The options were granted under the company's 2021 Equity Incentive Plan.
- The exercise price of each option is $0.76.
- The options vest in 48 equal monthly installments, becoming fully vested on February 14, 2029.
- The options expire on February 14, 2035.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock option grants, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock option grants to a company executive, which is a common practice in the biotechnology industry to incentivize and retain key personnel.
Stakeholder Impact
- The granting of stock options aligns the CFO's interests with those of the shareholders, incentivizing him to increase the company's value.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Date of transaction: Jonathan Lieber acquired 180,000 stock options. |
| 02/14/2029 | Options fully vest in 48 equal monthly installments. |
| 02/14/2035 | Expiration date of the options. |
| 02/19/2025 | Date of signature on the Form 4 filing. |
Keywords
stock options, Form 4, Rallybio Corp, RLYB, Jonathan Lieber, CFO, Equity Incentive Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.